Triligent, established in 1996, is a contract research organization that was formed to provide diverse services of the highest quality to the pharmaceutical, biologic and device industries. The key success factor for Triligent has been the timely, innovative, meticulous and cost-effective completion of projects ranging from focal research consulting (pre-clinical, clinical, regulatory and QA) through the conduct of international research programs. Triligent distinguishes itself from other Contract Research Organizations (CROs) by offering a highly trained staff that understands the intricacies of the research process regardless of the disease state being studied. We provide our clients with seasoned professionals, most with more than 15 years experience in their fields, and dedicated project teams that readily integrate as full participants in our client's research program. Our professionals have gained their many years of experience from within the FDA, contract research organizations, and various US and international pharmaceutical, device and biotech companies. Our professionals also regularly attend continuing education programs and participate as panel members in and chairs of internationally recognized seminars related to current US and international trends in Good Clinical Practice (GCP), Good Manufacturing Practice (GMP) and/or Good Laboratory Practice (GLP).
Triligent personnel are located around the US and throughout the world. Based upon the client's requirements, we identify members of our team who will best serve the client's needs and ask such members to volunteer for the project. Triligent has found that employing experienced and willing personnel on a project results in such personnel remaining on the job through to the end of the project, dedicated to providing the client with excellence and consistency in their services. The end result of Triligent's efforts has been a highly stable operation producing outstanding results for our clients proved by Triligent's high rate of repeat business.
Triligent International offers global support for pre-clinical and clinical research projects, from Phase I to IV, as well as regulatory support for projects through NDA submission. |
Robert Kagon, JD, RAC